Tổng số lượt xem trang

Thứ Bảy, 15 tháng 12, 2012

SIÊU ÂM TĨNH MẠCH CHỦ DƯỚI trong SỐC


Sonography has traditionally been used to assess anatomic abnormalities. However, its value in evaluating physiologic characteristics has recently been recognized, particularly in the care of patients in shock. As the use of point-of-care sonography grows in critical care and emergency medicine, noninvasive assessment of intravascular volume status is increasingly being used to guide therapy of the critically ill.

Although intravenous fluid is often the initial treatment in hypotensive patients, aggressive volume resuscitation may be detrimental in some patients and in certain types of shock. Accurate diagnosis of shock state can be challenging because physical findings of hypovolemic, distributive, cardiogenic, and obstructive shock often overlap. Pulmonary artery and central venous pressure catheters, which provide physiologic data such as cardiac output and right atrial pressure, are time-consuming, invasive, and carry considerable risks. Central venous pressure has long been used to guide fluid management; however, data suggest that in critically ill patients, central venous pressure may not correlate with the effective intravascular volume. Furthermore, invasive hemodynamic monitoring has not been shown to benefit patients.

Given the importance of determining intravascular volume in shock, a rapid bedside sonographic examination can be instrumental in guiding medical management of critically ill patients. Multiple sonographic protocols now exist for the evaluation of shock, dyspnea, and cardiac arrest.  This article will describe the use of sonography of the inferior vena cava (IVC) in the evaluation of patients in shock.


 



 
Physiology: IVC Parameters
The IVC is a compliant vessel that distends and collapses with pressure and volume changes. Although the absolute IVC size varies widely among healthy individuals and may not by itself be diagnostic, the maximal IVC diameter has been shown to be lower in patients with hypovolemia.5
A better indicator of intravascular volume is collapsibility of the IVC. As intrathoracic pressure decreases with inspiration, venous blood is pulled from the lower half of the body into the right atrium. This action causes a transient, but normal, decrease in the IVC diameter. With expiration, the IVC diameter increases and returns to its baseline. These changes are known as respirophasic variability. The IVC collapsibility index, also known as the caval index, is defined as the difference between the maximal (expiratory) and minimal (inspiratory) IVC diameters divided by the maximal diameter. The caval index is used in spontaneously breathing patients to estimate right atrial pressure.6,7 In patients with minimal respirophasic collapse, having the patient inspire forcefully, or sniff, will differentiate between patients with poor inspiratory effort and those with elevated right atrial pressure. The sniff method may provide more accurate estimation of volume status; however, measurements taken during normal respiration are reasonably accurate as well.8
Recent guidelines from the American Society of Echocardiography support the general use of IVC size and collapsibility in assessment of volume status.9 Studies have suggested the use of specific parameters for maximal IVC diameter and caval index to predict volume status.6,8 In one of these studies, using 2 cm as the cutoff for the maximal IVC diameter resulted in good sensitivity and specificity for predicting elevated right atrial pressure.8 A caval index greater than 50% suggests a low volume state,6 especially in combination with a small IVC diameter. Conversely, a low caval index with a large IVC diameter suggests a high volume state.
Inferior vena cava size does not predict right atrial pressure in patients receiving mechanical ventilation.10 Mechanical ventilation reverses the hemodynamics of venous return during the respiratory cycle. During positive pressure inspiration, intrathoracic pressure is increased, impeding blood flow from the IVC to the right atrium. During expiration, intrathoracic pressure is lower, and venous return increases. In a patient with normal right atrial pressure, this cyclic venous return produces minimal variation of the IVC size during the respiratory cycle. When a patient is volume depleted, however, the right atrium and IVC become more compliant, and the IVC size increases with positive pressure inspiration. Assessment of the IVC has been used in mechanically ventilated patients to predict whether fluid expansion is expected to increase the stroke volume and cardiac output. The variation of the IVC in positive pressure ventilation, known as the IVC distensibility index, is the difference between the maximum and minimum IVC diameters divided by the minimum diameter. In contrast to IVC collapsibility, which indicates volume status, the distensibility index has been used to assess preload dependence and predict fluid responsiveness such that the absence of respiratory variation suggests that volume expansion is unlikely to be effective.11,12 Fluid responsiveness is an emerging and important concept in critical care that seeks to avoid unnecessary fluid administration, which may expose the patient to risks of volume overload, when a fluid challenge is not expected to improve hemodynamics and organ perfusion.
Anatomy and Scanning Technique
A low-frequency phased array transducer (3.5–5 MHz) is used to evaluate the IVC, which lies in the retroperitoneum to the right of the aorta. It is differentiated by its thinner walls and respiratory flow variation. The IVC passes posterior to the liver and is joined by the hepatic veins before it enters the thoracic cavity and drains into the right atrium. There exists considerable variability in the literature regarding the location at which the IVC diameter should be measured. Most studies agree that the measurement should be distal to the junction with the right atrium and within 3 cm of that point.6,8,1214 Other studies measure the IVC at or near the junction with the hepatic veins.11,1520 A study comparing commonly measured locations found that respiratory variation of the IVC at the junction with the right atrium did not correlate with variation at sites distal to the hepatic veins.21 Guidelines from the American Society of Echocardiography recommend an assessment of the IVC just proximal to the hepatic veins, which lie approximately 0.5 to 3 cm from the right atrium.9
To image the IVC, the probe is placed in the subxiphoid 4-chamber position with the probe marker oriented laterally to identify the right ventricle and right atrium. As the probe is progressively aimed toward the spine, the convergence of the IVC with the right atrium will be seen. The IVC should be followed inferiorly, specifically looking for the confluence of the hepatic veins with the IVC (Figure 1). The IVC can also be evaluated in the long-axis plane. For this view, the probe is turned from a 4-chamber subxiphoid to a 2-chamber subxiphoid orientation, with the probe now in a longitudinal orientation (Figure 2). Although this view allows visualization of the IVC throughout the length of the hepatic segment, the true size of the IVC may be underestimated in the long axis due to a common error known as the cylinder tangent effect. This effect occurs when the ultrasound beam travels through the vessel longitudinally in an off-centered plane. One way to avoid underestimating the size of the IVC is to angle the probe laterally and medially until the greatest dimension is identified.
The diameter of the IVC should be measured perpendicular to the long axis of the IVC at end-expiration and end-inspiration. The finding of a small-diameter IVC with large inspiratory collapse (high caval index) correlates with low volume states. This phenomenon may be observed in hypovolemic and distributive shock states (Figures 3 and 4 and Videos 1 and 2). Conversely, a large IVC with minimal collapse (low caval index) suggests a high volume state such as cardiogenic or obstructive shock (Figures 5 and 6 and Videos 3 and 4). Movement of the diaphragm, especially during forceful inspiration or sniffing, may displace the IVC relative to the probe, making it difficult to obtain comparative measurements at the same location. In the short axis, the probe may need to be angled inferiorly during inspiration to locate the site measured at expiration. In the long axis, displacement of the IVC may require angling inferiorly and/or laterally (to avoid tangential measurement). In either orientation, it is recommended to observe the changes of the IVC through several respiratory cycles.
 
M-mode Doppler sonography of the IVC can be used to graphically document the absolute size and dynamic changes in the caliber of the vessel during the patient's respiratory cycle in both short and long axes (Figures 710). It should be noted, however, that M-mode sonography may introduce inaccurate measurements due to the displacement of the IVC relative to the probe during inspiration. Movement of the IVC out of the plane of the M-mode cursor may appear as vessel collapse on the M-mode tracing. It is therefore recommended that M-mode sonography be used after adequately visualizing IVC variability in the B-mode to avoid inaccurate estimation of vessel size and collapse.
Further studies are needed to define normal IVC parameters such as size, collapsibility, and distensibility (in mechanically ventilated patients). Until then, assessment of IVC collapsibility is useful in the critically ill patient whose caval index approaches the extremes. Additionally, caval sonography can be repeated during resuscitation to evaluate improvement of these parameters.
Evidence
Incorporation of a goal-directed sonographic protocol including assessment of the IVC has been shown to improve the accuracy of physician diagnosis in patients with undifferentiated hypotension.22 In a recent prospective study, point-of-care sonography evaluating cardiac contractility and IVC collapsibility in patients with suspected sepsis was shown to increase physician certainty and alter more than 50% of treatment plans.23 Inadequate dilatation of the IVC after a fluid challenge was more sensitive than blood pressure for identification of hypovolemia in trauma patients.24 Another study in trauma patients showed the value of bedside caval sonography in evaluation of fluid status and resuscitation of critically ill patients.25 A study in acutely dyspneic patients presenting to the emergency department showed that IVC sonography rapidly identifies patients with congestive heart failure and volume overload.26
Rather than relying on a single measurement of the IVC, it may be more useful to follow changes in vessel size and collapsibility over time in response to an intervention. Studies have shown a decrease in the IVC diameter and increased collapsibility after blood loss15 and fluid removal during hemodialysis.27 In hypotensive emergency patients, volume resuscitation was associated with increases in the IVC diameter and less inspiratory collapsibility.14 Just as a single blood pressure measurement is an incomplete representation of the hemodynamic status of a patient, sonography of the IVC should be repeated after interventions or changes in clinical parameters. Monitoring of the IVC diameter during resuscitation is an emerging area of research, and further studies are necessary to determine the exact parameters to interpret IVC size and collapsibility.
Pitfalls
The IVC should be followed to the junction with the right atrium to avoid misidentification with the aorta. Because a single long-axis view may be inaccurate, it is recommended to assess the IVC in both short and long axes. Inferior vena cava determinations should be made at or near the confluence with the hepatic veins. Measurements elsewhere may not reflect intravascular volume.
A dynamic evaluation of the degree of IVC collapse with inspiration may correlate better with the intravascular volume than a single static measurement of the vessel size. Inferior vena cava size does not predict right atrial pressure in patients receiving mechanical ventilation. Care should be taken to maintain adequate visualization of the IVC throughout the respiratory cycle because the probe and IVC may be displaced by diaphragmatic and abdominal wall movements. Overestimation of intravascular volume may occur in conditions that impede flow to the right heart, including valvular abnormalities, pulmonary hypertension, and heart failure.
Interpretation of caval physiology is hindered by conditions that restrict the physiologic variability of the IVC, such as liver cirrhosis and fibrosis,28 masses causing external compression, and elevated intra-abdominal pressure. Interpretation of the physiologic characteristics of the IVC should be done in context with the patient's clinical scenario and adjunctive data.
Conclusions
Determination of shock state in critically ill patients is challenging, but caval sonography may be a substitute for invasive hemodynamic monitoring. Assessment of the physiologic characteristics of the IVC provides a rapid distinction between low and high volume states and offers the clinician a rapid, noninvasive way to guide resuscitation in critically ill patients. In addition to caval sonography, focused echocardiography and lung sonography have been suggested by an increasing number of resuscitation sonography protocols to further evaluate patients in shock.

 

Thứ Ba, 11 tháng 12, 2012

ARFI for Nonalcoholic Fatty Liver


Abstract

PURPOSE:

To investigate the clinical usefulness of ultrasonography-based acoustic radiation force impulse (ARFI) elastography (ie, ARFI sonoelastography) in patients with a diagnosis of nonalcoholic fatty liver disease (NAFLD) and compare ARFI sonoelastography results with transient sonoelastography and serum fibrosis marker test results.

MATERIALS AND METHODS:

Written informed consent was obtained from all subjects, and the local ethics committee approved the study. Fifty-four patients with a liver biopsy-confirmed diagnosis of NAFLD (mean age, 50.6 years +/- 13.7) were examined. All patients with NAFLD and healthy volunteers underwent ARFI sonoelastography, transient sonoelastography, and serum liver fibrosis marker testing (hyaluronic acids, type IV collagen 7 S domain). Ten healthy volunteers underwent ARFI sonoelastography. ARFI sonoelastography results were compared with liver biopsy findings, the reference standard. ARFI sonoelastography findings were compared with liver biopsy, transient sonoelastography, and serum fibrosis marker test results. Student t testing was used for univariate comparisons; Kruskal-Wallis testing, for assessments involving more than two independent groups; and areas under the receiver operating characteristic curve (A(z)), to assess the sensitivity and specificity of ARFI sonoelastography for detection of stage 3 and stage 4 fibrosis.

RESULTS:

Median velocities in the patients with NAFLD were 1.040 m/sec for those with stage 0 fibrosis, 1.120 m/sec for those with stage 1, 1.130 m/sec for those with stage 2, 1.780 m/sec for those with stage 3, and 2.180 m/sec for those with stage 4. The A(z) for the diagnosis of hepatic fibrosis stages 3 or higher was 0.973 (optimal cutoff value, 1.77 m/sec; sensitivity, 100%; specificity, 91%), while that for the diagnosis of stage 4 fibrosis was 0.976 (optimal cutoff value, 1.90 m/sec; sensitivity, 100%; specificity, 96%). Significant correlations between median velocity measured by using ARFI sonoelastography and the following parameters were observed: liver stiffness measured with transient sonoelastography (r = 0.75, P < .0001), serum level of hyaluronic acid(r = 0.459, P = .0009), and serum level of type IV collagen 7 S domain (r = 0.445, P = .0015).

CONCLUSION:

There is a significant positive correlation between median velocity measured by using ARFI sonoelastography and severity of liver fibrosis in patients with NAFLD. The results of ARFI sonoelastography were similar to those of transient sonoelastography

 

Discussion

Our study results demonstrate a significant positive correlation between median ARFI sonoelastographic velocity and liver fibrosis severity in patients with NAFLD. NAFLD is now a common cause of chronic liver disease. Its incidence in adults and children is rapidly increasing because of ongoing epidemics of obesity and type 2 diabetes (21,22). Patients with NAFLD can be divided into two categories: those with simple steatosis and those with NASH at liver biopsy. However, liver biopsy is an invasive and expensive procedure and is associated with a relatively high risk of complications (7). The biopsy procedure results in pain in 25% of all patients (23), and the risk of severe complications has been reported to be 3.1 cases per 1000 procedures (24). Moreover, the accuracy of biopsy for assessing the severity of liver fibrosis remains questionable, and intra- and interobserver variations have been observed (8,9,2527). Furthermore, sampling errors are often reported, even in patients with NASH (28). Thus, a rapid and noninvasive method of detecting fibrosis in patients with NAFLD is of major clinical interest.

From an imaging viewpoint, we previously reported that transient sonoelastography can be used to measure fibrosis in patients with NAFLD (10,11). Recently, ARFI sonoelastography has been used to generate internal mechanical excitation noninvasively, and this method has attracted a great deal of attention for its use in the measurement of liver stiffness. Friedrich-Rust et al (29) compared ARFI imaging with both transient sonoelastography and serum fibrosis marker testing for the noninvasive assessment of liver fibrosis in patients with viral hepatitis. They reported that the results of US-based ARFI imaging for noninvasive measurement of liver fibrosis were comparable to those of transient sonoelastography and serum fibrosis marker testing.

To our knowledge, no investigators had previously evaluated the utility of ARFI sonoelastography for the assessment of liver fibrosis specifically in patients with NAFLD. Our results demonstrate that the median velocity measured by using ARFI sonoelastography increases as the fibrotic stage increases in these patients. The results also demonstrate a significant relationship between median ARFI sonoelastographic velocity and transient sonoelastographic liver stiffness measurement. Although we found a positive correlation between median ARFI sonoelastographic velocity and serum levels of liver fibrosis markers, the r values were relatively weak; thus, it is unlikely that this correlation can be used clinically.

The major advantages of transient sonoelastography and ARFI sonoelastography, as compared with liver biopsy, are that these techniques are painless, rapid, and have no associated complications and are, therefore, very easily accepted by patients. Moreover, ARFI sonoelastography can be integrated into a conventional US system by using conventional US probes and therefore can be performed during standard US examinations of the liver, which are routinely performed in patients with chronic liver disease.

We found that the optimal median ARFI velocity for the diagnosis of NASH with severe fibrosis (stages 3 and 4) was 1.77 m/sec. Thus, in the future, patients with median velocities of more than 1.77 m/sec should be closely followed up, because it is likely that they have NASH with severe fibrosis. On the other hand, there is a possibility that the patients with a low median velocity might have simple steatosis. Therefore, in the future, patients with a low median velocity measured by using ARFI might be spared from undergoing liver biopsy.

We also found that the median velocity in patients with simple steatosis was lower than that in healthy volunteers. Possible reasons for this observation include the hypothesis that steatosis makes the liver softer because of fat deposition in the liver parenchyma. Unlike viral hepatitis, NASH has two aspects: steatosis and fibrosis. Therefore, in patients with NAFLD, it may be difficult to distinguish between simple steatosis and NASH with mild fibrosis with use of ARFI sonoelastography, although it can be performed more conveniently than transient sonoelastography.

One limitation of our study was that we calculated our accuracy measurements on the basis of the population being studied; therefore, our results are optimized for this specific population and likely include overestimations of performance. Another limitation was the relatively small number of patients, particularly those with higher grades of liver fibrosis. Because of this, we may not have adequately assessed the biologic variability in the patients with higher grades of fibrosis. Selection bias was another limitation because in this study, we did not examine patients who had any clinical evidence of hepatic decompensation. Furthermore, the liver biopsies were performed up to 12 months before ARFI sonoelastography and transient sonoelastography. There is the possibility that the degrees of steatosis and fibrosis had changed for the period. In this study, the same person performed the ARFI sonoelastographic and transient sonoelastographic examinations; this was an advantage because the two examinations could be performed with the patient in the same position. However, it cannot be denied that knowledge of other examinations could have biased results. At present, we have no choice but to depend on liver biopsy for the diagnosis of NASH.

In conclusion, to our knowledge, this is the first study conducted to investigate the potential clinical usefulness of a US-based ARFI elastography technique as a noninvasive method of assessing liver fibrosis in patients with NAFLD. Further investigation is required to ensure that ARFI sonoelastographic measurements are useful diagnostic markers of NASH.

Advances in Knowledge

*          There is a stepwise increase in the median velocity measured by using acoustic radiation force impulse (ARFI) sonoelastography with increasing histologic severity of hepatic fibrosis in fatty liver disease.

*          The median velocity in patients with simple steatosis is lower than that in healthy volunteers.

*          There is a relationship between median velocity measured by using ARFI sonoelastography and liver stiffness measured by using transient sonoelastography.

Implications for Patient Care

*          ARFI sonoelastography can be performed during standard US examinations of the liver, which are routinely performed in patients with chronic liver disease.

*          ARFI sonoelastography is a rapid and noninvasive method of detecting fibrosis in patients with nonalcoholic fatty liver disease.